Stockreport

Homology Medicines Presents Data Showing Single Dose HMI-102 Resulted in Long-Term Correction of PKU, Including Reduction of Phe and Increased Brain Neurotransmitters in Murine Model

Homology Medicines, Inc.  (FIXX) 
Last homology medicines, inc. earnings: 3/12 04:10 pm Check Earnings Report
PDF - Phase 1/2 pheNIX Study of Gene Therapy Candidate HMI-102 is Underway and Initial Clinical Data is Anticipated by Year End - BEDFORD, Mass., June 17, 2019 (GLOBE NEW [Read more]